YOUNGBLOOD DR KNEELAND 4
4 · Light & Wonder, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
YOUNGBLOOD DR KNEELAND
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-07+3,320→ 23,912 total - Award
Restricted Stock Units
2024-06-05+2,159→ 2,159 total→ Common Stock (2,159 underlying) - Exercise/Conversion
Restricted Stock Units
2024-06-07−3,320→ 0 total→ Common Stock (3,320 underlying)
Footnotes (2)
- [F1]The restricted stock units are scheduled to vest on the earlier of (a) the date of the issuer's 2025 annual meeting of stockholders and (b) June 5, 2025. Each unit converts into a share of common stock on a one-for-one basis.
- [F2]Represents the vesting of restricted stock units granted on June 7, 2023. The award has fully vested. Each unit converted into a share of common stock on a one-for-one basis.